Search - tctmd.com

Displaying 21 - 40 of 64

Sort: Relevancy | Date

Presentation TCTAP 2013

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Presenter: Seung-Jung Park

April 24, 2013

Presentation TCTAP 2013

Surgical AVR Remains the Procedure of Choice for Most AS Patients

Presenter: David P. Taggart

April 24, 2013

Presentation TCTAP 2013

Surgery Should Be the Dominant Therapy

Presenter: David P. Taggart

April 24, 2013

Presentation TCTAP 2013

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

Presenter: David J. Cohen

April 24, 2013

Presentation TCTAP 2013

No More Device, Lack of Evidence

Presenter: Ted Feldman

April 24, 2013

Presentation TCTAP 2013

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Presenter: Adnan Kastrati

April 24, 2013

Presentation TCTAP 2013

Controversies: TAVI is Preferred in All High-Risk Patients

Presenter: Alain Cribier

April 24, 2013

Presentation TCTAP 2012

Why FFR and Why Not FFR in Bifurcation Lesions

Presenter: Bon-Kwon Koo

April 26, 2012

Presentation TCTAP 2012

Update of Dedicated Bifurcation Stents

Presenter: Martin B. Leon

April 26, 2012

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation with Balloon and Self Expandable Devices: Results from the Milan Registry

Presenter: Alaide Chieffo

April 26, 2012

Presentation TCTAP 2012

Tips and Tricks of IVUS Guided Reverse CART

Presenter: Masahiko Ochiai

April 26, 2012

Presentation TCTAP 2012

The EXCEL Trial Design, Status, and Timelines

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Risk Scores for Appropriate Left Main Revascularization

Presenter: Corrado Tamburino

April 26, 2012

Presentation TCTAP 2012

Results of RESOLUTE Series of Studies

Presenter: Martin B. Leon

April 26, 2012

Presentation TCTAP 2012

Re-Emergence of Local Drug Delivery: Challenges and Opportunities

Presenter: Juan F. Granada

April 26, 2012

Presentation TCTAP 2012

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

Presenter: Cheol Whan Lee

April 26, 2012

Presentation TCTAP 2012

My Top 10 Rules in Non-LM Bifurcation Stenting

Presenter: Antonio Colombo

April 26, 2012

Presentation TCTAP 2012

Minimal Lumen Area Matched with Fractional Flow Reserve: Answers for 10 Questions

Presenter: Soo-Jin Kang

April 26, 2012

Presentation TCTAP 2012

Long Lesion Treatment Lesson From Large Registry

Presenter: Jung-Min Ahn

April 26, 2012

Presentation TCTAP 2012

Indian TUXEDO Trial In Medically Treated Diabetics

Presenter: Upendra Kaul

April 26, 2012

Advertisement

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Surgical AVR Remains the Procedure of Choice for Most AS Patients

Surgery Should Be the Dominant Therapy

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

No More Device, Lack of Evidence

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Controversies: TAVI is Preferred in All High-Risk Patients

Why FFR and Why Not FFR in Bifurcation Lesions

Update of Dedicated Bifurcation Stents

Transcatheter Aortic Valve Implantation with Balloon and Self Expandable Devices: Results from the Milan Registry

Tips and Tricks of IVUS Guided Reverse CART

The EXCEL Trial Design, Status, and Timelines

Risk Scores for Appropriate Left Main Revascularization

Results of RESOLUTE Series of Studies

Re-Emergence of Local Drug Delivery: Challenges and Opportunities

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

My Top 10 Rules in Non-LM Bifurcation Stenting

Minimal Lumen Area Matched with Fractional Flow Reserve: Answers for 10 Questions

Long Lesion Treatment Lesson From Large Registry

Indian TUXEDO Trial In Medically Treated Diabetics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content